An Introduction to Pharmacovigilance 2nd Edition at Meripustak

An Introduction to Pharmacovigilance 2nd Edition by Patrick Waller, JOHN WILEY

Books from same Author: Patrick Waller

Books from same Publisher: JOHN WILEY

Related Category: Author List / Publisher List


  • Price: ₹ 3740.00/- [ 25.01% off ]

    Seller Price: ₹ 2805.00

Sold By: Store4Doctors      Click for Bulk Order

Free Shipping (for orders above ₹ 499) *T&C apply.

In Stock

Free Shipping Available



Click for International Orders
  • Provide Fastest Delivery

  • 100% Original Guaranteed
  • General Information  
    Author(s)Patrick Waller
    PublisherJOHN WILEY
    Edition2nd
    ISBN9781119289746
    Pages192
    BindingPaperback
    LanguageEnglish
    Publish YearMay 2017

    Description

    JOHN WILEY An Introduction to Pharmacovigilance 2nd Edition by Patrick Waller

    Pharmacovigilance is the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other drug-related problems.

    This introductory guide is designed to aid the rapid understanding of the key principles of pharmacovigilance. Packed full of examples illustrating drug safety issues it not only covers the processes involved, but the regulatory aspects and ethical and societal considerations of pharmacovigilance. 

    Covering the basics step-by-step, this book is perfect for beginners and is essential reading for those new to drug safety departments and pharmaceutical medicine students. The second edition is thoroughly revised and updated throughout and includes a new chapter on clinical aspects of pharmacovigilance.

    ABOUT THE AUTHOR:
    Patrick Waller MD, MPH, FRCPEd, FFPM, Formerly Honorary Professor, London School of Hygiene and Tropical Medicine, London, United Kingdom.

    Mira Harrison-Woolrych BM, DM, DFFP, FRCOG, Honorary Research Associate Professor, Dunedin School of Medicine, University of Otago, New Zealand; Senior Medical Assessor, Vigilance and Risk Management, Medicines and Healthcare products Regulatory Agency (MHRA), London, UK and Secretary General of the International Society of Pharmacovigilance (ISoP).